Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis

被引：59

作者：

Andonopoulos, AP ^{[1
]}

Meimaris, N ^{[1
]}

Daoussis, D ^{[1
]}

Bounas, A ^{[1
]}

Giannopoulos, G ^{[1
]}

机构：

[1] Univ Patras, Sch Med, Dept Med, Div Rheumatol, Patras 26500, Greece

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷 / 11期

关键词：

D O I：

10.1136/ard.62.11.1116

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1116 / 1116

页数：1

共 12 条

[1] Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs [J].

Airo, P ;

Antonioli, CM ;

Vianelli, M ;

Toniati, P .

RHEUMATOLOGY, 2002, 41 (03) :347-349

[2]

Brandt J, 2000, ARTHRITIS RHEUM-US, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO

[3]

2-E

[4]

Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO

[5]

2-Y

[6] Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis [J].

Field, M ;

Cook, A ;

Gallagher, G .

RHEUMATOLOGY INTERNATIONAL, 1997, 17 (03) :113-118

[7] Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica [J].

Gabriel, SE ;

Sunku, J ;

Salvarani, C ;

OFallon, WM ;

Hunder, GG .

ARTHRITIS AND RHEUMATISM, 1997, 40 (10) :1873-1878

[8] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[9]

Mattey DL, 2000, ARTHRITIS RHEUM, V43, P1749, DOI 10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO

[10]

2-K

← 1 2 →